Takeda to announce U.S. dollar senior note offering

Osaka, Japan, July 9, 2012 – Takeda Pharmaceutical Company Limited (“Takeda”) announced today a U.S. dollar senior note offering. Takeda intends to use the proceeds from the note offering to partially repay short-term interest-bearing debt which resulted from the acquisition of Nycomed A/S, headquartered in Zurich, Switzerland on September 30, 2011.

An outline of the senior note offering is as follows:

1. Type of Securities: U.S. dollar unsecured senior notes
2. Maturity: 3 years (due in March 2015), 5 years (due in March 2017)
3. Offering Method: Private offering in foreign markets including the USA, Europe and Asia (planned)

Details of the issuance, including the issue amount, issue price, maturity date, coupon and issue date, will be determined at a later and disclosed on a timely basis.

Note:

This document is prepared for the purpose of public disclosure of determination of the terms of the securities and does not constitute a solicitation of an offer for acquisition or an offer for sale of any securities in or outside of the United States or Japan. The securities set forth above have not been and will not be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Latest News Release